Gateway Investment Advisers LLC Raises Holdings in Humana Inc. $HUM

Gateway Investment Advisers LLC grew its holdings in Humana Inc. (NYSE:HUM) by 110.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,652 shares of the insurance provider’s stock after purchasing an additional 1,390 shares during the period. Gateway Investment Advisers LLC’s holdings in Humana were worth $1,053,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Montag A & Associates Inc. lifted its holdings in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 94 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new stake in Humana in the 4th quarter worth about $27,000. Reflection Asset Management purchased a new position in Humana in the 4th quarter worth about $29,000. Global Assets Advisory LLC bought a new position in Humana during the 1st quarter valued at about $38,000. Finally, Larson Financial Group LLC boosted its holdings in shares of Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after acquiring an additional 81 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Price Performance

NYSE HUM opened at $388.86 on Thursday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The stock has a market cap of $46.69 billion, a price-to-earnings ratio of 36.79, a PEG ratio of 2.13 and a beta of 0.72. The company’s 50 day moving average is $380.56 and its two-hundred day moving average is $274.05. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue was up 26.2% on a year-over-year basis. During the same period in the prior year, the business posted $6.27 earnings per share. As a group, research analysts anticipate that Humana Inc. will post 9.09 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have commented on HUM. The Goldman Sachs Group lifted their target price on shares of Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a research report on Thursday, April 30th. Bank of America raised Humana from a “neutral” rating to a “buy” rating and set a $500.00 target price on the stock in a research report on Wednesday, July 29th. Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 price target for the company in a research report on Thursday, July 30th. Barclays upped their price target on shares of Humana from $344.00 to $407.00 and gave the company an “equal weight” rating in a research report on Friday, July 31st. Finally, Raymond James Financial downgraded shares of Humana from an “outperform” rating to a “market perform” rating in a report on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, fourteen have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $395.22.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.